SCHEMBL6131745

SCHEMBL6131745

Oc1cc(O)c2ccc(-c3cc(O)c(O)c(O)c3)[o+]c2c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 10/20 0.73
GLO1 Q04760 5/20 0.58
SNCA P37840 3/20 0.58
EGFR P00533 2/20 0.58
KDR P35968 2/20 0.58
EP300 Q09472 2/20 0.58
CREBBP Q92793 2/20 0.58
F2 P00734 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
DPP4 P27487 2/20 0.46
OR51E2 Q9H255 2/20 0.46
SIRT1 Q96EB6 1/20 0.40
MAOA P21397 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTPRS Q13332 1/20 0.33
MEN1 O00255 1/20 0.33
ABCC1 P33527 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6131747 0.98 CD38 (0.71) CD38GLO1SNCAEGFRKDR
Luteolinidin SCHEMBL30159678 0.85 CD38 (1.00) CD38GLO1SNCAEGFRKDR
Luteolinidin SCHEMBL676808 0.85 CD38 (1.00) CD38GLO1SNCAEGFRKDR
SCHEMBL5692415 0.84 CD38 (0.76) CD38GLO1SNCAEGFRKDR
Luteolinidin SCHEMBL676807 0.83 CD38 (0.97) CD38GLO1SNCAEGFRKDR
Hydrochloric Acid SCHEMBL1366891 0.83 CD38 (0.73) CD38GLO1SNCAEGFRKDR
Hydrochloric Acid SCHEMBL29413086 0.83 CD38 (0.73) CD38GLO1SNCAEGFRKDR
SCHEMBL11155009 0.83 CD38 (0.69) CD38GLO1SNCAEGFRKDR
Hydrochloric Acid SCHEMBL29392598 0.83 CD38 (0.73) CD38GLO1SNCAEGFRKDR
Hydrochloric Acid SCHEMBL11317960 0.81 CD38 (0.71) CD38GLO1SNCAEGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1172090-B1 Skin dyeing compositions comprising dihydroxyacetone and a flavylium salt non substituted in position 3 OREAL (FR) 2005-03-09 EP claimed
EP-1172093-B1 Compositions for coloring the skin containing flavylium salt compounds unsubstituted in position 3 and an organomodified silicone OREAL (FR) 2004-12-01 EP claimed
EP-1172092-B1 Compositions for coloring the skin containing at least one UV filter and flavylium salt compounds unsubstituted in position 3 OREAL (FR) 2004-09-15 EP claimed
US-6558655-B2 Substituted with at least one hydroxyl group or alkoxy radical. Société l'Oréal S.A. (FR) 2003-05-06 US claimed
US-6537528-B2 Coloration close to that of a natural tan and which may be stable over time L'OREAL S.A. (FR) 2003-03-25 US claimed
US-6511656-B2 Compositions for coloring the skin comprising at least one flavylium salt which is unsubstituted in position 3 and at least one organomodified silicone L'OREAL S.A. (FR) 2003-01-28 US claimed
US-6471949-B2 COSMETICS; FOR ARTIFICIALLY COLORING THE SKIN L'OREAL S.A. (FR) 2002-10-29 US claimed
US-20020064507-A1 Compositions comprising at least one UV screening agent and at least one flavylium salt which is unsubstituted in position 3, for coloring the skin, and uses thereof L'OREAL S.A. (FR) 2002-05-30 US claimed
US-20020051755-A1 Composition comprising at least one self-tanning agent chosen from monocarbonyl and polycarbonyl compounds and a flavylium salt compound which is unsubstituted in position 3, for coloring the skin, and uses thereof L'OREAL S.A. (FR) 2002-05-02 US claimed
US-20020048555-A1 Artificial tanning compositions comprising flavylium salts SOCIETE L'OREAL S.A. (FR) 2002-04-25 US claimed
US-20020048556-A1 Compositions for coloring the skin comprising at least one flavylium salt which is unsubstituted in position 3 and at least one organomodified silicone L'OREAL S.A (FR) 2002-04-25 US claimed
US-20050169856-A1 Coloring composition, process of making, uses thereof L'OREAL (FR) 2005-08-04 US disclosed
EP-1559392-A1 Process for preparing a composition for permanent or semipermanent dyeing of skin, eyebrows, lips or nails from a fluid under pressure and dyestuffs L'OREAL (FR) 2005-08-03 EP disclosed
EP-1172090-B1 Skin dyeing compositions comprising dihydroxyacetone and a flavylium salt non substituted in position 3 OREAL (FR) 2005-03-09 EP disclosed
EP-1172093-B1 Compositions for coloring the skin containing flavylium salt compounds unsubstituted in position 3 and an organomodified silicone OREAL (FR) 2004-12-01 EP disclosed
US-20020048555-A1 Artificial tanning compositions comprising flavylium salts SOCIETE L'OREAL S.A. (FR) 2002-04-25 US disclosed
EP-1172090-A1 Skin dyeing compositions containing at least a mono or polycarbonyl self-tanning compound and a flavylium salt non substituted in position 3 L'OREAL (FR) 2002-01-16 EP disclosed
EP-1172091-A1 Skin dyeing compositions containing flavylium salt compounds non substituted in position 3 L'OREAL (FR) 2002-01-16 EP disclosed
EP-1172092-A1 Skin dyeing compositions containing at least an uv filter and a non substituted in position 3 flavylium salt L'OREAL (FR) 2002-01-16 EP disclosed
EP-1172093-A1 Skin dyeing compositions containing flavylium salt compounds non substituted in position 3 and an organomodified silicone L'OREAL (FR) 2002-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020064507-A1 Compositions comprising at least one UV screening agent and at least one flavylium salt which is unsubstituted in position 3, for coloring the skin, and uses thereof TYR, CUTA, POLR1C CD38 4238/4885GLO1 523/4885SNCA 1118/4885
US-20020048556-A1 Compositions for coloring the skin comprising at least one flavylium salt which is unsubstituted in position 3 and at least one organomodified silicone CUTA, LPO, TYR CD38 4862/4885GLO1 98/4885SNCA 1660/4885
US-20020048555-A1 Artificial tanning compositions comprising flavylium salts ADH7, TYR, HADHB CD38 3003/4885GLO1 101/4885SNCA 3981/4885
US-20050169856-A1 Coloring composition, process of making, uses thereof CUTA, TYR, POLR1C CD38 3979/4885GLO1 926/4885SNCA 2679/4885
US-20020051755-A1 Composition comprising at least one self-tanning agent chosen from monocarbonyl and polycarbonyl compounds and a flavylium salt compound which is unsubstituted in position 3, for coloring the skin, and uses thereof TYR, CUTA, MITF CD38 3110/4885GLO1 412/4885SNCA 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.